Renato Malcher‐Lopes
Biographic Data
| ID | 7842080 |
|---|---|
| NAME | Renato Malcher‐Lopes |
| GIVEN NAMES | Renato |
| FAMILY NAME | Malcher‐Lopes |
| SIGNATURE | LOPES R M |
| AFFILIATIONS | Universidade de Brasília |
| ORCID | 0000-0002-4941-9908 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Cannabidiol Compared to Pharmacological Treatment as Usual for Crack Use Disorder
Cannabidiol (CBD) has been studied for substance use disorders treatment due to its anxiolytic effects, for sleep, appetite, reduction of craving, and maintenance of abstinence. The study aims to assess CBD’s feasibility, safety/tolerability, and preliminary efficacy compared to pharmacological treatment as usual for reducing crack use in people with crack use disorder (CUD) and investigate other parameters: adverse events, physical health sympto…
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms
Autism Spectrum Disorders (ASD) may significantly impact the well-being of patients and their families. The therapeutic use of cannabis for ASD has gained interest due to its promising results and low side effects, but a consensus on treatment guidelines is lacking. In this study, we conducted a retrospective analysis of 20 patients with autistic symptoms who were treated with full-spectrum cannabis extracts (FCEs) in a response-based, individual…
Addressing the stimulant treatment gap
No prominent works on this page.
Addressing the stimulant treatment gap
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms
Autism Spectrum Disorders (ASD) may significantly impact the well-being of patients and their families. The therapeutic use of cannabis for ASD has gained interest due to its promising results and low side effects, but a consensus on treatment guidelines is lacking. In this study, we conducted a retrospective analysis of 20 patients with autistic symptoms who were treated with full-spectrum cannabis extracts (FCEs) in a response-based, individual…
Cannabidiol Compared to Pharmacological Treatment as Usual for Crack Use Disorder
Cannabidiol (CBD) has been studied for substance use disorders treatment due to its anxiolytic effects, for sleep, appetite, reduction of craving, and maintenance of abstinence. The study aims to assess CBD’s feasibility, safety/tolerability, and preliminary efficacy compared to pharmacological treatment as usual for reducing crack use in people with crack use disorder (CUD) and investigate other parameters: adverse events, physical health sympto…
Cannabis and Cannabinoid Research (3 works) · Medicine (3 works) · Psychiatry (3 works) · Cannabidiol (2 works) · Cannabis (2 works) · Internal Medicine (2 works) · Psychology (2 works) · Addiction (1 work) · Alternative medicine (1 work) · Autism (1 work)